VitriVax · 6 days ago
Scientist, Particle Characterization
VitriVax, Inc. is creating thermostable, single-injection vaccines using an innovative technology platform called ALTA®. The Scientist in the Particle Characterization group will develop and apply analytical methods to characterize spray dried particles and ALTA™ products, working closely with a team of scientists and engineers.
BiotechnologyMedicalMedical DeviceTherapeutics
Responsibilities
In-house subject matter expert for ALTA™ and spray dried particle characterization
Remains up to date on particle characterization techniques and manages testing by 3 parties (academic or CDMO)
Recommends/specifies equipment for purchase that has high potential to address routine characterization or QC testing of ALTA™ products and intermediates
Supports the investigation of bulk material properties and surface chemistry towards the goal of understanding product performance
Independently designs, executes and authors reports summarizing material properties of ALTA™ particles, intermediates and processes
Supports investigations of ALTA™ manufacturing processes
Works closely with Formulation Development and Particle Engineering to establish product specifications and conduct stability studies
Supports Quality Control testing to support, in-process, product release, and stability testing
Contributes toward portions of IND or BLA eCTD module 2 and 3
Adheres to Company policies and laboratory notebook and safety guidelines
Qualification
Required
A PhD degree in Analytical Chemistry, Material Science, or related field with dissertation characterizing powder properties
An in-depth understanding of particle size analysis techniques
Experience in solid-state characterization, encompassing X-ray powder diffraction, X-ray photoelectron spectroscopy, differential scanning calorimetry, thermogravimetric analysis, among others
Experience with a variety of general analytical techniques (i.e. Karl Fisher, surface area analysis, SEM, pycnometry, ICP-MS, AAS, powder flowability and friability, etc.)
Background working with lyophilized or spray dried pharmaceutical products, particularly with proteins, lipids, and/or mRNA lyophilization is a plus
Understanding of ICH Q6, Q8, Q9, Q10, and Quality by Design
Proficient in the use of statistical analysis methods and standard office tools like Excel and Word
Benefits
Stock Options
401(k) with generous Company match
Flexible work schedule and PTO
Health, Dental and Vision insurance
Short Term Disability insurance and Voluntary AD&D Insurance
Company
VitriVax
VitriVax is a formulation technology company that engineers solutions to maximize the accessibility and utility of human vaccines.
Funding
Current Stage
Growth StageTotal Funding
$35.75MKey Investors
Bill & Melinda Gates FoundationAdjuvant Capital
2025-10-22Series B· $17.25M
2025-10-14Grant· $9.9M
2024-12-04Grant· $3.6M
Recent News
2025-10-25
2025-10-24
Venture Capital Firms
2025-10-23
Company data provided by crunchbase